Simplex Trading, LLC Lineage Cell Therapeutics, Inc. Transaction History

Simplex Trading, LLC

  • $2.98 Billion
  • Q2 2024

A detailed history of Simplex Trading, LLC transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 2,855 shares of LCTX stock, worth $2,598. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,855
Previous 6,299 54.68%
Holding current value
$2,598
Previous $9,000 77.78%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
SELL
$0.89 - $1.47 $3,065 - $5,062
-3,444 Reduced 54.68%
2,855 $2,000
Q1 2024

Apr 25, 2024
SELL
$0.86 - $1.48 $2,801 - $4,820
-3,257 Reduced 34.08%
6,299 $9,000
Q4 2023

Feb 02, 2024
BUY
$0.91 - $1.35 $7,485 - $11,105
8,226 Added 618.5%
9,556 $10,000
Q3 2023

Nov 01, 2023
SELL
$1.16 - $1.53 $61 - $81
-53 Reduced 3.83%
1,330 $1,000
Q2 2023

Aug 04, 2023
BUY
$1.26 - $1.53 $1,742 - $2,115
1,383 New
1,383 $1,000
Q2 2022

Aug 03, 2022
SELL
$1.12 - $1.61 $4,631 - $6,657
-4,135 Closed
0 $0
Q1 2022

May 02, 2022
SELL
$1.21 - $2.48 $2,332 - $4,781
-1,928 Reduced 31.8%
4,135 $6,000
Q4 2021

Feb 23, 2022
SELL
$1.84 - $2.68 $83,388 - $121,457
-45,320 Reduced 88.2%
6,063 $14,000
Q2 2021

Aug 12, 2021
SELL
$2.17 - $3.0 $43,892 - $60,681
-20,227 Reduced 28.25%
51,383 $146,000
Q1 2021

Apr 26, 2021
BUY
$1.77 - $3.1 $126,749 - $221,991
71,610 New
71,610 $168,000
Q4 2020

Feb 02, 2021
SELL
$0.95 - $1.83 $12,363 - $23,815
-13,014 Closed
0 $0
Q3 2020

Oct 14, 2020
SELL
$0.75 - $1.09 $225 - $327
-300 Reduced 2.25%
13,014 $12,000
Q2 2020

Jul 13, 2020
BUY
$0.71 - $1.18 $9,452 - $15,710
13,314 New
13,314 $11,000
Q1 2020

Apr 29, 2020
SELL
$0.6 - $1.58 $51 - $134
-85 Closed
0 $0
Q4 2019

Feb 05, 2020
BUY
$0.54 - $1.01 $6 - $12
12 Added 16.44%
85 $0
Q3 2019

Oct 15, 2019
BUY
$0.85 - $1.24 $62 - $90
73 New
73 $0

Others Institutions Holding LCTX

# of Institutions
121
Shares Held
94.3M
Call Options Held
31.3K
Put Options Held
400
View Full List

About Lineage Cell Therapeutics, Inc.

LCTX Quotes by TradingView
  • Ticker LCTX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 169,755,008
  • Market Cap $154M
  • Description
  • Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...
More about LCTX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email